We are live on ! Find out more
PCM

Palisade Capital Management Portfolio holdings

AUM $3B
1-Year Est. Return 14%
This Fund
S&P 500
This Quarter Est. Return
+1.92%
1 Year Est. Return
+14%
3 Year Est. Return
+46.63%
5 Year Est. Return
+57.43%
10 Year Est. Return
+263.17%
AUM
$3.06B
AUM Growth
-$19.3M
Cap. Flow
-$438M
Cap. Flow %
-14.34%
Top 10 Hldgs %
10.54%
Holding
577
New
48
Increased
148
Reduced
183
Closed
48

Sector Composition

Rank Sector Weight
1 Industrials 14.42%
2 Technology 14.26%
3 Consumer Discretionary 10.26%
4 Healthcare 10.09%
5 Financials 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SM icon
126
SM Energy
SM
$7.18B
$7.45M 0.24%
397,767
+38,089
+11% +$525K
CNR
127
DELISTED
Cornerstone Building Brands, Inc.
CNR
$7.45M 0.24%
524,584
+50,632
+11% +$565K
PFE icon
128
Pfizer
PFE
$146B
$7.43M 0.24%
264,329
-4,181
-2% -$119K
GPN icon
129
Global Payments
GPN
$24.3B
$7.17M 0.23%
+109,755
New +$6.51M
VOD icon
130
Vodafone
VOD
$35.4B
$7.14M 0.23%
222,810
-29,299
-12% -$912K
JAH
131
DELISTED
JARDEN CORPORATION
JAH
$7.07M 0.23%
119,937
-143,926
-55% -$7.7M
JACK icon
132
Jack in the Box
JACK
$346M
$7.05M 0.23%
110,348
-3,897
-3% -$274K
LXFR icon
133
Luxfer Holdings
LXFR
$458M
$7.04M 0.23%
663,990
+62,986
+10% +$640K
SYNA icon
134
Synaptics
SYNA
$3.96B
$6.92M 0.23%
86,842
-58,009
-40% -$4.4M
BCC icon
135
Boise Cascade
BCC
$2.99B
$6.85M 0.22%
330,693
-41,436
-11% -$781K
CFR icon
136
Cullen/Frost Bankers
CFR
$10.4B
$6.83M 0.22%
123,836
-7,852
-6% -$406K
WCG
137
DELISTED
Wellcare Health Plans, Inc.
WCG
$6.82M 0.22%
73,547
-85,597
-54% -$7.1M
MDLZ icon
138
Mondelez International
MDLZ
$79.8B
$6.78M 0.22%
168,976
-7,004
-4% -$285K
UNP icon
139
Union Pacific
UNP
$175B
$6.56M 0.21%
82,460
+20,630
+33% +$1.59M
CUBE icon
140
CubeSmart
CUBE
$9.46B
$6.31M 0.21%
189,382
-3,925
-2% -$121K
INVX
141
Innovex International
INVX
$2.13B
$6.18M 0.2%
102,104
+9,780
+11% +$545K
MIDD icon
142
Middleby
MIDD
$6.14B
$6.17M 0.2%
57,784
-12,428
-18% -$1.17M
PARA
143
DELISTED
Paramount Global Class B
PARA
$6.17M 0.2%
111,980
-4,690
-4% -$228K
INTU icon
144
Intuit
INTU
$89B
$6.16M 0.2%
59,220
+51,242
+642% +$4.95M
ALK icon
145
Alaska Air
ALK
$5.81B
$6.12M 0.2%
74,665
-20,125
-21% -$1.49M
HW
146
DELISTED
Headwaters Inc
HW
$6.09M 0.2%
306,966
+50,511
+20% +$847K
NVO
147
Novo Nordisk
NVO
$197B
$6.05M 0.2%
223,300
-2,030
-0.9% -$54.4K
NBIX icon
148
Neurocrine Biosciences
NBIX
$16.6B
$5.74M 0.19%
145,162
-61,455
-30% -$2.44M
BEAV
149
DELISTED
B/E Aerospace Inc
BEAV
$5.72M 0.19%
123,962
-1,758
-1% -$75.2K
COLM icon
150
Columbia Sportswear
COLM
$2.94B
$5.69M 0.19%
+94,698
New +$5.2M

Similar funds

Palisade Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Palisade Capital Management held 577 positions worth $3.06B, down 0.63% from $3.08B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Palisade Capital Management withdrew a net $438M in Q1 2016, closing 48 positions and reducing 183 holdings. Its most notable exit was BIOMED REALTY TRUST INC, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Palisade Capital Management opened a new position in Steven Madden worth $7.89M.

  • Palisade Capital Management's largest Q1 2016 buy was Steven Madden: 319,521 shares worth $7.89M.
  • Palisade Capital Management added most to HEICO Corp in Q1 2016, an estimated $6.73M increase.
  • Palisade Capital Management's biggest Q1 2016 reduction was Acadia Healthcare, cutting an estimated $11.8M.
  • Palisade Capital Management fully exited BIOMED REALTY TRUST INC in Q1 2016, selling an estimated $13.8M.
  • Palisade Capital Management's ten largest holdings make up 11% of its $3.06B portfolio in Q1 2016.
  • Palisade Capital Management opened 48 new positions and closed 48 in Q1 2016.
  • Palisade Capital Management's portfolio value fell 0.63% quarter-over-quarter to $3.06B.

Based on Palisade Capital Management's 13F filing for Q1 2016, filed 11 May 2016.